Corneal biomechanical changes of SMILE versus LASIK

Article

Patients with myopia of greater than -6.00 dioptres (D) who underwent femtosecond laser-assisted LASIK, experienced a more significant decrease in corneal hysteresis, corneal resistance factor, and p1 and p2 areas than patients who underwent small incision lenticule extraction (SMILE).

Patients with myopia of greater than -6.00 dioptres (D) who underwent femtosecond laser-assisted LASIK, experienced a more significant decrease in corneal hysteresis, corneal resistance factor, and p1 and p2 areas than patients who underwent small incision lenticule extraction (SMILE).

Researchers in China studied 187 eyes that were treated with SMILE and 79 eyes that were treated with LASIK. The eyes were also grouped by degree of myopia: -68.00 D or less, or greater than -6.00 D. In all patients, corneal hysteresis, corneal resistance factor, and 37 waveform parameters were compared preoperatively, and at 1 week and 1 and 3 months postoperatively.

Using an Ocular Response Analyzer (Reichert Ophthalmic Instruments) the researchers noted in both the SMILE patients and the LASIK patients a significant decrease of corneal hysteresis, corneal resistance factor, p1 area, and p2 area. The differences in these parameters between the two procedures were not significant in patients who had myopia of -6.00 D or less. However, in patients with myopia greater than -6.00 D, all of the parameters decreased significantly more in the eyes that underwent LASIK than in those that underwent SMILE.

The findings were reported in the Journal of Refractive Surgery.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.